Literature DB >> 3694224

Life spans of Duchenne muscular dystrophy patients in the hospital care program in Japan.

M Mukoyama1, K Kondo, K Hizawa, H Nishitani.   

Abstract

Analysis of 176 autopsy cases of Duchenne muscular dystrophy (DMD) demonstrated that (1) hospitalized patients showed longer life spans than their non-hospitalized affected maternal uncles, (2) patients hospitalized recently lived longer than those hospitalized in the past, and (3) pulmonary infection has become a less frequent cause of death in recent years, whereas dystrophic changes of the cardiac and respiratory muscles are more closely related with recent fatal cases. These results indicate the changing life span expectancy of patients with DMD and the changes in cause of death over the last decade, probably owing to the benefits of a hospital care program.

Entities:  

Mesh:

Year:  1987        PMID: 3694224     DOI: 10.1016/0022-510x(87)90092-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model.

Authors:  B A Valentine; J F Cummings; B J Cooper
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

2.  Chronic hypoxia impairs muscle function in the Drosophila model of Duchenne's muscular dystrophy (DMD).

Authors:  Matias Mosqueira; Gabriel Willmann; Hannele Ruohola-Baker; Tejvir S Khurana
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

Review 3.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

4.  Severe cardiomyopathy in mice lacking dystrophin and MyoD.

Authors:  L A Megeney; B Kablar; R L Perry; C Ying; L May; M A Rudnicki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

5.  Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.

Authors:  John P Bourke; Teofila Bueser; Rosaline Quinlivan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16

6.  Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.

Authors:  Naoko Yugeta; Nobuyuki Urasawa; Yoko Fujii; Madoka Yoshimura; Katsutoshi Yuasa; Michiko R Wada; Masao Nakura; Yoshiki Shimatsu; Masayuki Tomohiro; Akio Takahashi; Noboru Machida; Yoshito Wakao; Akinori Nakamura; Shin'ichi Takeda
Journal:  BMC Cardiovasc Disord       Date:  2006-12-04       Impact factor: 2.298

7.  Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.

Authors:  John P Bourke; Gillian Watson; Francesco Muntoni; Stefan Spinty; Helen Roper; Michela Guglieri; Chris Speed; Elaine McColl; Ashish Chikermane; Sandeep Jayawant; Satish Adwani; Tracey Willis; Jennifer Wilkinson; Andrew Bryant; Thomas Chadwick; Ruth Wood; Kate Bushby
Journal:  BMJ Open       Date:  2018-12-19       Impact factor: 2.692

8.  The intracellular Ca2+ concentration is elevated in cardiomyocytes differentiated from hiPSCs derived from a Duchenne muscular dystrophy patient.

Authors:  Fumitoshi Tsurumi; Shiro Baba; Daisuke Yoshinaga; Katsutsugu Umeda; Takuya Hirata; Junko Takita; Toshio Heike
Journal:  PLoS One       Date:  2019-03-15       Impact factor: 3.240

9.  Nonsustained ventricular tachycardia does not affect the prognosis of neuromuscular diseases: A preliminary and retrospective study.

Authors:  Takahiro Kamihara; Fumihiko Yasuma; Toyoaki Murohara
Journal:  J Arrhythm       Date:  2018-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.